{"id":538,"date":"2021-06-10T15:14:46","date_gmt":"2021-06-10T19:14:46","guid":{"rendered":"https:\/\/www.cqc-qcc.ca\/?post_type=qcc_members&#038;p=538"},"modified":"2021-10-28T15:46:05","modified_gmt":"2021-10-28T19:46:05","slug":"michael-sebag","status":"publish","type":"qcc_members","link":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/","title":{"rendered":"Michael Sebag, MD, PhD"},"content":{"rendered":"\n<p class=\"is-style-intro-text wp-block-paragraph\">Dr. Michael Sebag has been working towards improving the lives of patients with Multiple Myeloma (MM) and related disorders since 2006.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">His focus has been on the preclinical development of novel drugs that target largely unexploited pathways in MM. In collaboration with medicinal chemistry at McGill, his team has developed completely new and interesting molecules that are at various stages of testing and development. His clinical focus has been on early phase, first in human clinical trials in MM. In addition, he is involved in the development of investigator-led clinical trials that are conducted across Canada. As the director of the McGill Immune Effector Cell program, he is also planning to bring exciting new therapies to patients with MM and other hematologic malignancies.<\/p>\n","protected":false},"featured_media":663,"parent":0,"menu_order":82,"template":"","qcc_members_institution":[33],"class_list":["post-538","qcc_members","type-qcc_members","status-publish","has-post-thumbnail","hentry","qcc_members_institution-mcgill-university-health-centre-research-institute-muhc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Michael Sebag, MD, PhD - Qu\u00e9bec Cancer Consortium<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michael Sebag, MD, PhD - Qu\u00e9bec Cancer Consortium\" \/>\n<meta property=\"og:description\" content=\"Dr. Michael Sebag has been working towards improving the lives of patients with Multiple Myeloma (MM) and related disorders since 2006. His focus has been on the preclinical development of novel drugs that target largely unexploited pathways in MM. In collaboration with medicinal chemistry at McGill, his team has developed completely new and interesting molecules [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/\" \/>\n<meta property=\"og:site_name\" content=\"Qu\u00e9bec Cancer Consortium\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-28T19:46:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/06\/no-photo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@QConsortium\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/\",\"url\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/\",\"name\":\"Michael Sebag, MD, PhD - Qu\u00e9bec Cancer Consortium\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/no-photo.jpg\",\"datePublished\":\"2021-06-10T19:14:46+00:00\",\"dateModified\":\"2021-10-28T19:46:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/no-photo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/no-photo.jpg\",\"width\":500,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/michael-sebag\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Members\",\"item\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/members-and-partners\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Michael Sebag, MD, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/\",\"name\":\"Consortium qu\u00e9b\u00e9cois contre le cancer\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/#organization\",\"name\":\"Quebec Cancer Consortium\",\"url\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Logo_QCC_ENG_rgb.png\",\"contentUrl\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Logo_QCC_ENG_rgb.png\",\"width\":3075,\"height\":1520,\"caption\":\"Quebec Cancer Consortium\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cqc-qcc.ca\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/QConsortium\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/consortium-qu\u00e9becois-contre-le-cancer-470238221\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Michael Sebag, MD, PhD - Qu\u00e9bec Cancer Consortium","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/","og_locale":"en_US","og_type":"article","og_title":"Michael Sebag, MD, PhD - Qu\u00e9bec Cancer Consortium","og_description":"Dr. Michael Sebag has been working towards improving the lives of patients with Multiple Myeloma (MM) and related disorders since 2006. His focus has been on the preclinical development of novel drugs that target largely unexploited pathways in MM. In collaboration with medicinal chemistry at McGill, his team has developed completely new and interesting molecules [&hellip;]","og_url":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/","og_site_name":"Qu\u00e9bec Cancer Consortium","article_modified_time":"2021-10-28T19:46:05+00:00","og_image":[{"width":500,"height":500,"url":"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/06\/no-photo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@QConsortium","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/","url":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/","name":"Michael Sebag, MD, PhD - Qu\u00e9bec Cancer Consortium","isPartOf":{"@id":"https:\/\/www.cqc-qcc.ca\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/#primaryimage"},"image":{"@id":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/06\/no-photo.jpg","datePublished":"2021-06-10T19:14:46+00:00","dateModified":"2021-10-28T19:46:05+00:00","breadcrumb":{"@id":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/#primaryimage","url":"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/06\/no-photo.jpg","contentUrl":"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/06\/no-photo.jpg","width":500,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/michael-sebag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.cqc-qcc.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Members","item":"https:\/\/www.cqc-qcc.ca\/en\/members-and-partners\/"},{"@type":"ListItem","position":3,"name":"Michael Sebag, MD, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cqc-qcc.ca\/en\/#website","url":"https:\/\/www.cqc-qcc.ca\/en\/","name":"Consortium qu\u00e9b\u00e9cois contre le cancer","description":"","publisher":{"@id":"https:\/\/www.cqc-qcc.ca\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cqc-qcc.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cqc-qcc.ca\/en\/#organization","name":"Quebec Cancer Consortium","url":"https:\/\/www.cqc-qcc.ca\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cqc-qcc.ca\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/09\/Logo_QCC_ENG_rgb.png","contentUrl":"https:\/\/www.cqc-qcc.ca\/wp-content\/uploads\/2021\/09\/Logo_QCC_ENG_rgb.png","width":3075,"height":1520,"caption":"Quebec Cancer Consortium"},"image":{"@id":"https:\/\/www.cqc-qcc.ca\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/QConsortium","https:\/\/www.linkedin.com\/in\/consortium-qu\u00e9becois-contre-le-cancer-470238221\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.cqc-qcc.ca\/en\/wp-json\/wp\/v2\/qcc_members\/538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cqc-qcc.ca\/en\/wp-json\/wp\/v2\/qcc_members"}],"about":[{"href":"https:\/\/www.cqc-qcc.ca\/en\/wp-json\/wp\/v2\/types\/qcc_members"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cqc-qcc.ca\/en\/wp-json\/wp\/v2\/media\/663"}],"wp:attachment":[{"href":"https:\/\/www.cqc-qcc.ca\/en\/wp-json\/wp\/v2\/media?parent=538"}],"wp:term":[{"taxonomy":"qcc_members_institution","embeddable":true,"href":"https:\/\/www.cqc-qcc.ca\/en\/wp-json\/wp\/v2\/qcc_members_institution?post=538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}